Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 6.77 is 35% below its 5-year average of 10.34, near the low end of its 5-year range (4.40–21.68).
As of the fiscal period ended Tuesday, June 30, 2026. 30.33% above its 12-month average of 5.20.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 6.77.
CURRENT RATIO
6.77
CURRENT RATIO AVG TTM
5.20
CURRENT RATIO AVG 3Y
7.49
CURRENT RATIO AVG 5Y
10.34
CURRENT RATIO AVG 10Y
9.74
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+30.33%
CURRENT VS 3Y AVG
-9.53%
CURRENT VS 5Y AVG
-34.52%
CURRENT VS 10Y AVG
-30.47%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
+80.11%
vs the sector median at left
Syndax Pharmaceuticals, Inc.
Market Cap
$1.54B
Current Ratio
6.77
TTM Avg
5.20
3Y Avg
7.49
5Y Avg
10.34
Market Cap
$1.57B
Current Ratio
7.69
TTM Avg
5.54
3Y Avg
6.46
5Y Avg
10.83
Market Cap
$1.50B
Current Ratio
1.52
TTM Avg
1.81
3Y Avg
2.10
5Y Avg
3.34
Market Cap
$1.59B
Current Ratio
4.69
TTM Avg
5.56
3Y Avg
3.02
5Y Avg
3.21
Market Cap
$1.49B
Current Ratio
15.72
TTM Avg
30.76
3Y Avg
24.36
5Y Avg
24.36
Market Cap
$1.48B
Current Ratio
2.96
TTM Avg
2.86
3Y Avg
3.00
5Y Avg
3.00
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Syndax Pharmaceuticals, Inc. (SNDX) | $1.54B | 6.77 | 5.20 | 7.49 | 10.34 |
| Innoviva, Inc. (INVA)vs › | $1.54B | 16.01 | 8.50 | 7.33 | 23.22 |
| Stoke Therapeutics, Inc. (STOK)vs › | $1.57B | 7.69 | 5.54 | 6.46 | 10.83 |
| Nutex Health, Inc. (NUTX)vs › | $1.50B | 5.00 | 2.75 | 2.21 | 2.87 |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.50B | 1.52 | 1.81 | 2.10 | 3.34 |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.59B | 4.69 | 5.56 | 3.02 | 3.21 |
| Rapport Therapeutics, Inc. Common Stock (RAPP)vs › | $1.49B | 15.72 | 30.76 | 24.36 | 24.36 |
| Phibro Animal Health Corporation (PAHC)vs › | $1.48B | 2.96 | 2.86 | 3.00 | 3.00 |
| uniQure N.V. (QURE)vs › | $1.60B | 10.01 | 10.09 | 8.82 | 10.31 |
| GH Research PLC (GHRS)vs › | $1.48B | 28.70 | 25.68 | 28.23 | 39.79 |
Current Ratio
6.77
Quick Ratio
6.44
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 6.77 |
| 2026-03-31 | 5.47 |
| 2025-12-31 | 4.40 |
| 2025-09-30 | 4.64 |
| 2025-06-30 | 4.71 |
| 2025-03-31 | 5.80 |
| 2024-12-31 | 5.82 |
| 2024-09-30 | 6.99 |
| 2024-06-30 | 10.50 |
| 2024-03-31 | 8.93 |
| 2023-12-31 | 10.00 |
| 2023-09-30 | 9.73 |
| 2023-06-30 | 13.56 |
| 2023-03-31 | 18.61 |
| 2022-12-31 | 16.85 |
| 2022-09-30 | 17.19 |
| 2022-06-30 | 12.69 |
| 2022-03-31 | 13.75 |
| 2021-12-31 | 21.68 |
| 2021-09-30 | 8.30 |
| 2021-06-30 | 10.81 |
| 2021-03-31 | 11.35 |
| 2020-12-31 | 15.84 |
| 2020-09-30 | 11.71 |
| 2020-06-30 | 15.39 |
| 2020-03-31 | 5.55 |
| 2019-12-31 | 3.39 |
| 2019-09-30 | 4.09 |
| 2019-06-30 | 4.90 |
| 2019-03-31 | 6.24 |
| 2018-12-31 | 5.18 |
| 2018-09-30 | 5.63 |
| 2018-06-30 | 5.43 |
| 2018-03-31 | 7.06 |
| 2017-12-31 | 8.45 |
| 2017-09-30 | 8.73 |
| 2017-06-30 | 11.66 |
| 2017-03-31 | 8.83 |
| 2016-12-31 | 10.47 |
| 2016-09-30 | 12.82 |
| 2016-06-30 | 19.44 |
| 2016-03-31 | 19.30 |
| 2015-12-31 | 18.16 |
| 2015-09-30 | 7.52 |
| 2015-06-30 | 0.00 |
| 2015-03-31 | 0.00 |
| 2014-12-31 | 1.20 |
| 2014-09-30 | 1.23 |
| 2014-06-30 | 1.12 |
| 2014-03-31 | 4.68 |
| 2013-12-31 | 5.33 |
| 2013-09-30 | 0.53 |
| 2013-06-30 | 0.00 |
| 2013-03-31 | 0.00 |
| 2012-12-31 | 0.03 |
